NTRB Nutriband Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRB

Price (delayed)

$7.35

Market cap

$89.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.53

Enterprise value

$86.14M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 15

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ ...

Highlights
The EPS has soared by 82% YoY and by 79% from the previous quarter
Nutriband's net income has increased by 32% YoY and by 14% from the previous quarter
Nutriband's gross profit has decreased by 39% YoY but it has increased by 4.9% QoQ
Nutriband's gross margin has increased by 17% QoQ but it has decreased by 3.8% YoY
Nutriband's equity has decreased by 37% YoY and by 11% QoQ
Nutriband's revenue has decreased by 37% YoY and by 10% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://nutriband.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of NTRB

NTRB stock price

How has the Nutriband stock price performed over time
Intraday
8.73%
1 week
4.4%
1 month
57.51%
1 year
4.4%
YTD
61.89%
QTD
130.41%

Financial performance

How have Nutriband's revenue and profit performed over time
Revenue
$1.62M
Gross profit
$536,121
Operating income
-$7.05M
Net income
-$6.96M
Gross margin
33.1%
Net margin
-430.4%
Nutriband's gross profit has decreased by 39% YoY but it has increased by 4.9% QoQ
Nutriband's revenue has decreased by 37% YoY and by 10% from the previous quarter
NTRB's operating income is up by 32% year-on-year and by 14% since the previous quarter
Nutriband's net income has increased by 32% YoY and by 14% from the previous quarter

Price vs fundamentals

How does NTRB's price correlate with its fundamentals

Growth

What is Nutriband's growth rate over time

Valuation

What is Nutriband stock price valuation
P/E
N/A
P/B
16.77
P/S
55.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
53.25
The EPS has soared by 82% YoY and by 79% from the previous quarter
The stock's price to book (P/B) is 157% more than its 5-year quarterly average of 6.0 and 81% more than its last 4 quarters average of 8.5
Nutriband's equity has decreased by 37% YoY and by 11% QoQ
The P/S is 115% more than the 5-year quarterly average of 23.6 and 84% more than the last 4 quarters average of 27.6
Nutriband's revenue has decreased by 37% YoY and by 10% from the previous quarter

Efficiency

How efficient is Nutriband business performance
Nutriband's return on equity has surged by 74% QoQ and by 73% YoY
The return on assets has surged by 74% since the previous quarter and by 73% year-on-year
The return on invested capital has surged by 60% year-on-year and by 31% since the previous quarter
The ROS has contracted by 8% YoY but it has grown by 4% from the previous quarter

Dividends

What is NTRB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRB.

Financial health

How did Nutriband financials performed over time
The total liabilities is down by 43% YoY but it is up by 7% QoQ
Nutriband's total assets has decreased by 38% YoY and by 9% QoQ
Nutriband's debt is 96% less than its equity
Nutriband's equity has decreased by 37% YoY and by 11% QoQ
Nutriband's debt to equity has increased by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.